Bioworld Financial Watch articles from September 2003

Bioworld Financial Watch archives from September 2003

Signs suggest open IPO window; 'time is right' for biotech sector.
September 1, 2003... Just when "IPO" had begun to sound like a code acronym or something from a foreign language, biotechnology's long drought with regard to initial public offerings seems to have ended with an August downpour. Apparently not fearing the risk...

U.S. public offering performance by underwriter: Jan. 1-Aug. 20, 2003 *.
September 1, 2003... UNDERWRITERS' PERFORMANCE ON ALL PUBLIC OFFERINGS JAN. 1-AUG. 20, 2003: FULL CREDIT TO ALL UNDERWRITERS, RANKED BY GROSS PROCEEDS * Underwriter Gross (Number Of Offerings As Lead/Number Proceeds Of...

BioWorld stock report for public biotechnology companies.
September 1, 2003... BioWorld Stock Report For Public Biotechnology Companies %Change Company Symbol Close Close WK YTD Vol 8/22 8/29 ...

Amgen payout ends patent fight; Genentech adding plant capacity.
September 8, 2003... As everybody in the biotechnology 'hood knows, big dogs can fight longer than smaller dogs--and Genentech Inc.'s legal scrap with Amgen Inc. over the way Amgen makes the blockbusters Neupogen and Neulasta dragged on for almost seven years. ...

Public financing of biotechnology: August 2003.
September 8, 2003... Public Financing Of Biotechnology: August 2003 I. COMMENCED TRADING IN AUGUST Company Date Date Shares/ Price Shares (Symbol) Filed Comm. Units (M) Out ...

Other financings of public biotechnology companies: August 2003.
September 8, 2003... Other Financings Of Public Biotechnology Companies: August 2003 TOTAL: $929.541M Company Type Of Number Of Amount (Symbol) (#) Financing Shares, Units Raised ...

Venture capital and corporate investments in biotechnology companies: August 2003.
September 8, 2003... Venture Capital And Corporate Investments In Biotechnology Companies: August 2003 I. FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $357.9M Company Location Date Amt. (M) ActivBiotics Lexington,...

BioWorld stock report for public biotechnology companies.
September 8, 2003... BioWorld Stock Report For Public Biotechnology Companies % Change Company Symbol Close Close Vol 8/29 9/5 WK ...

Axokine's promise still alive: Regeneron restarting program.
September 15, 2003... "Regeneron's CNTF Drug Could Push Leptin Out Of Obesity Race," trumpeted a BioWorld Financial Watch headline in late 2000. "Obesity's Next Savior? Leader Axokine Ready For Phase III," declared another the following year. By April 2003, it was:...

Clinical trial update: August 2003.
September 15, 2003... Clinical Trial Update: August 2003 Company * Product Description (Country; Symbol) AUTOIMMUNE Antisense ATL1102 Antisense drug that Therapeutics (ISIS 107248) inhibits...

Non-U.S. clinical trials, regulatory submissions, recommendations and approvals: August 2003.
September 15, 2003... Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: August 2003 Company * Product Description (Country; Symbol) CANCER Corixa Corp. Bexxar A...

FDA submissions, approvals and other actions: August 2003.
September 15, 2003... FDA Submissions, Approvals And Other Actions: August 2003 Company (a) Product Description Indication (Country; Symbol) AUTOIMMUNE Amgen Inc. Enbrel Etanercept; Rheumatoid...

BioWorld stock report for public biotechnology companies.
September 15, 2003... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close 9/5 9/12 Aastrom Biosci ASTM 1.34 1.592 Abgenix ABGX 13.51 15.18...

Genome, 'reach-through' claims changing name of biotech game.
September 22, 2003... "Big deal." The sarcastic phrase in everyday life is often used to imply the opposite of its literal meaning, but a big deal is what many smaller biotechnology companies live for--and some can't live without. Getting a would-be partner...

Biotech mergers and acquisitions: May 29-Sept. 17, 2003 (#).
September 22, 2003... Biotech Mergers And Acquisitions: May 29-Sept. 17, 2003 (#) 1. COMPLETED MERGERS AND ACQUISITIONS Company Acquired By Date Acquired * Or Merged With * Announced (Country; Symbol) (Country;...

BioWorld stock report for public biotechnology companies.
September 22, 2003... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close 9/12 9/19 Aastrom Biosci ASTM 1.592 1.64 Abgenix ABGX ...

BioMarin abandons Neutralase; PKU drug tempting Genzyme?
September 29, 2003... It's all about the enzymes. Strike that. More precisely, much drug development these days seems to be about the enzymes, as replacement therapies and as treatments. Revise that to add: But the enzymes don't always work. The shifting...

Correction.
September 29, 2003... In the Sept. 22, 2003, issue of BioWorld Financial Watch, a second reference to the Millennium/Ortho deal should have said it was for the development of Velcade. Editor's note: The correction has been made on BioWorld Online.

Biotech--big pharma collaborations: new agreements, July 24-Sept. 24, 2003 (#).
September 29, 2003... Biotech--Big Pharma Collaborations: New Agreements, July 24 - Sept. 24, 2003 (#) Biotech Co. * Pharma Co. Type/Product Area (Country; (Country) Symbol) Aclara GlaxoSmithKline ...

Manufacturing, marketing and distribution agreements between Biotech and Pharmaceutical companies: July 24-Sept. 24, 2003 (#).
September 29, 2003... Manufacturing, Marketing And Distribution Agreements Between Biotech and Pharmaceutical Companies: July 24-Sept. 24, 2003 (#) Biotech Co. * Pharma Co. Product (Country; (Country) Symbol) Advanced...

Biotech--Big Pharma collaborations: modified and terminated agreements, July 24-Sept. 24, 2003 (#).
September 29, 2003... Biotech--Big Pharma Collaborations: Modified And Terminated Agreements, July 24-Sept. 24, 2003 (#) I. MODIFIED AGREEMENTS Biotech Co. * Pharma Co. Change from original (Country; (Country) ...

BioWorld stock report for public biotechnology companies.
September 29, 2003... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close 9/19 9/26 Aastrom Biosci ASTM 1.64 1.53 Abgenix ABGX 16.58 ...